Evidence map›Paper›PMID 34524871›Full record

ArticleMolecular biology of the cell2021

Riboflavin transporter SLC52A1, a target of p53, suppresses cellular senescence by activating mitochondrial complex II.

Taiki Nagano, Yuto Awai, Shione Kuwaba, Taiichi Osumi, Kentaro Mio, Tetsushi Iwasaki, Shinji Kamada

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Taiki NaganoBiosignal Research Center, Kobe University, Nada-ku, Kobe 657-8501, Japan.
Yuto AwaiDepartment of Biology, Faculty of Science, Kobe University, Nada-ku, Kobe 657-8501, Japan.
Shione KuwabaDepartment of Biology, Faculty of Science, Kobe University, Nada-ku, Kobe 657-8501, Japan.
Taiichi OsumiDepartment of Biology, Graduate School of Science, Kobe University, Nada-ku, Kobe 657-8501, Japan.
Kentaro MioDepartment of Biology, Graduate School of Science, Kobe University, Nada-ku, Kobe 657-8501, Japan.
Tetsushi IwasakiBiosignal Research Center, Kobe University, Nada-ku, Kobe 657-8501, Japan.
Shinji KamadaBiosignal Research Center, Kobe University, Nada-ku, Kobe 657-8501, Japan.
Kobe University · JPBiosignatures (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular senescence is a state of permanent proliferative arrest induced by a variety of stresses, such as DNA damage. The transcriptional activity of p53 has been known to be essential for senescence induction. It remains unknown, however, whether among the downstream genes of p53, there is a gene that has antisenescence function. Our recent studies have indicated that the expression of SLC52A1 (also known as GPR172B/RFVT1), a riboflavin transporter, is up-regulated specifically in senescent cells depending on p53, but the relationship between senescence and SLC52A1 or riboflavin has not been described. Here, we examined the role of SLC52A1 in senescence. We found that knockdown of

Indexed as

Cell Line, TumorCellular SenescenceElectron Transport Complex IIHumansMembrane Potential, MitochondrialMembrane Transport ProteinsMitochondriaMitochondrial MembranesReceptors, G-Protein-CoupledRiboflavinSignal TransductionTumor Suppressor Protein p53Electron Transport Complex IIMembrane Transport ProteinsReceptors, G-Protein-CoupledRiboflavinSLC52A1 protein, humanTumor Suppressor Protein p53

Identifiers

PMID34524871
PMCPMC8693961
OpenAlexW3199931524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.